[Skip to Content]

Upstate Active Clinical Trials

Study Title:

An Observational, Longitudinal, Prospective, Long-Term Registry of Patients with
Hypophosphatasia. Protocol ALX-HPP-501.

What is the purpose of the study?

Conducting this study to learn about patients who have Hypophosphatasia (HPP). HPP is an ultra-rare bone disorder caused by gene mutations or changes. These gene mutations result in low or absent levels of an enzyme needed to harden you or your child’s bones.
This study does not involve any treatment for HPP.

Upstate Institutional Review Board (IRB) Number:

773478

Study/Protocol ID:

ALX-HPP-501

Study Phase:

N/A

Patient Age Group:

Adults and Children

Principal Investigator:

Ruban Dhaliwal

Who can I contact for more information?

Name: Jane D Bulger
Phone: 315-464-9008
Email: bulgerj@upstate.edu

Return to Previous Page || Search Again

Top